TRD
Showing 1 - 25 of 316
Auditory MMN EEG in TRD in Response to Ketamine
Not yet recruiting
- Treatment-resistant Depression (TRD)
- (no location specified)
Jul 14, 2022
Treatment Resistant Depression (TRD) Trial (Vagus Nerve Stimulation (VNS), Best Medical Treatment)
Not yet recruiting
- Treatment Resistant Depression (TRD)
- Vagus Nerve Stimulation (VNS)
- Best Medical Treatment
- (no location specified)
Jul 17, 2023
MDD, Bipolar Disorder, Unipolar Major Depression Trial run by the National Institute of Mental Health (NIMH) (MagPro TMS
Recruiting
- Major Depressive Disorder
- +2 more
- MagPro TMS Stimulator and coil
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Healthy, Overweight and Obesity Trial in Hangzhou (refined carbohydrate breakfast, whole grain breakfast, energy-restricted
Recruiting
- Healthy
- Overweight and Obesity
- refined carbohydrate breakfast
- +3 more
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
Mar 23, 2023
Depressive Disorder, Treatment-Resistant Trial in Edmonton (Repetitive Transcranial Magnetic Stimulation (rTMS),
Completed
- Depressive Disorder, Treatment-Resistant
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Internet-Delivered Cognitive Behavior Therapy (iCBT)
-
Edmonton, Alberta, CanadaEdmonton Mental Health Clinic
Jul 31, 2022
Depression Trial (Vagus Nerve Stimulation, Transcranial Magnetic Stimulation)
Not yet recruiting
- Depression
- Vagus Nerve Stimulation
- Transcranial Magnetic Stimulation
- (no location specified)
Feb 2, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC, Open label TBS-DLPFC)
Completed
- Treatment Resistant Depression
- Active TBS-DLPFC
- +2 more
-
Stanford, CaliforniaDepartment of Psychiatry and Behavioral Sciences, Stanford Schoo
Apr 29, 2022
Moderate Depression, MDD, Severe Depression Trial in Beijing (4 session rTMS, 6 session rTMS, 8 session rTMS)
Not yet recruiting
- Moderate Depression
- +2 more
- 4 session rTMS
- +4 more
-
Beijing, Beijing, ChinaWuhan Mental Health Center
Oct 29, 2023
MDD, Treatment Resistant Depression Trial in New York (Medtronic Percept PC DBS system)
Recruiting
- Major Depressive Disorder
- Treatment Resistant Depression
- Medtronic Percept PC DBS system
-
New York, New YorkIcahn School of Medicine at Mount Sinai, Mount Sinai West
Mar 6, 2023
Treatment-Resistant Depression Trial in Hangzhou (non-invasive transcranial deep brain stimulation, Sham stimulation, Motor
Recruiting
- Treatment-Resistant Depression
- non-invasive transcranial deep brain stimulation
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Mar 8, 2023
Treatment Resistant Depression, Electroconvulsive Therapy, ECT Trial in United States (electroconvulsive therapy (ECT),
Recruiting
- Treatment Resistant Depression
- +8 more
- electroconvulsive therapy (ECT)
- Ketamine
-
New Haven, Connecticut
- +4 more
Mar 11, 2022
Treatment-Resistant Depression Trial (MIJ821 Subcutaneous Injection - low dose, MIJ821 Subcutaneous Injection - medium dose,
Not yet recruiting
- Treatment-Resistant Depression
- MIJ821 Subcutaneous Injection - low dose
- +3 more
- (no location specified)
Jul 8, 2022
Treatment Resistant MDD Trial (Almond Therapy, Intranasal ketamine (Esketamine), Treatment as Usual)
Not yet recruiting
- Treatment Resistant Major Depressive Disorder
- Almond Therapy
- +2 more
- (no location specified)
Jun 24, 2022
Treatment Resistant MDD Trial in Canada, United States (Aripiprazole, Repetitive transcranial magnetic stimulation (rTMS),
Completed
- Treatment Resistant Major Depressive Disorder
- Aripiprazole
- +2 more
-
Birmingham, Alabama
- +12 more
Apr 26, 2022
Treatment Resistant Depression Trial in Atlanta (Medtronic Activa PC+S System)
Active, not recruiting
- Treatment Resistant Depression
- Medtronic Activa PC+S System
-
Atlanta, GeorgiaEmory University
Aug 16, 2021
MDD, Treatment Resistant Depression Trial in New York (AXS-05, Bupropion SR)
Enrolling by invitation
- Major Depressive Disorder
- Treatment Resistant Depression
- AXS-05
- Bupropion SR
-
New York, New YorkAxsome Research Site
Jul 20, 2021
MDD, Treatment Resistant Depression Trial in New York (Medtronic Summit RC+S DBS system)
Recruiting
- Major Depressive Disorder
- Treatment Resistant Depression
- Medtronic Summit RC+S DBS system
-
New York, New YorkIcahn School of Medicine at Mount Sinai, Mount Sinai West
Sep 23, 2021
MDD, Depression Trial in Vancouver (repetitive transcranial magnetic stimulation)
Completed
- Major Depressive Disorder
- Depression
- repetitive transcranial magnetic stimulation
-
Vancouver, British Columbia, CanadaNon-Invasive Neurostimulation Therapies lab, University of Briti
Jan 8, 2021
Treatment Resistant Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Treatment Resistant Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Little Rock, Arkansas
- +19 more
Jul 8, 2022
Treatment Resistant Depression Trial in Germany, Poland, United States (PCN-101, Placebo)
Completed
- Treatment Resistant Depression
- PCN-101
- Placebo
-
Little Rock, Arkansas
- +20 more
Dec 19, 2022
Treatment Resistant Depression, MDD Trial in United States (AXS-05 (dextromethorphan-bupropion))
Completed
- Treatment Resistant Depression
- Major Depressive Disorder
- AXS-05 (dextromethorphan-bupropion)
-
Little Rock, Arkansas
- +19 more
Jun 2, 2022